Eldecalcitol clinical trials
How each study uses eldecalcitol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the eldecalcitol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2023 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 4
Xi'an Honghui Hospital (1) · Chugai Pharmaceutical (1) · Chinese SLE Treatment And Research Group (1) · Shanghai Jiao Tong University Affiliated Sixth People's Hospital (1) · Shinshu University (1) · e-GLORIA trial Protocol Review Committee (1)
Studies
Open first, then newest update. How each study uses eldecalcitol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild OsteoporosisRecruitingPhase 4Shanghai Jiao Tong University Affiliated Sixth People's HospitalNCT05902078Written as Eldecalcitol capsules
- A Study on the Prevention and Treatment of GIOP With EldecalcitolNot yet recruitingPhase 4Chinese SLE Treatment And Research GroupNCT06385093Written as Eldecalcitol capsules
- Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)CompletedPhase 4Xi'an Honghui HospitalNCT05884372Written as Eldecalcitol
- The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With OsteoporosisStatus unknownPhase 1Shinshu UniversityNCT02306187Written as Edirol
- Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus AlfacalcidolStatus unknownNot applicablee-GLORIA trial Protocol Review CommitteeNCT01974167Written as Eldecalcitol
- A New Active Vitamin D, ED-71 for OsteoporosisCompletedPhase 3Chugai PharmaceuticalNCT00144456Written as ED-71
Given beside what is tested · 1 — eldecalcitol is usual care or a partner of the new treatment
Codes
What other systems call eldecalcitol · ClinicalTrials.gg INT005580
- MeSH (NLM) C547512eldecalcitolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) I2JP8UE90HELDECALCITOLConfirmed FDA, NLM, Wikidata
- Wikidata Q5353912eldecalcitolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87291EldecalcitolOne source FDA
- DrugBank DB05295One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C547512 | eldecalcitol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | I2JP8UE90H | ELDECALCITOL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5353912 | eldecalcitol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87291 | Eldecalcitol | One source FDA |
| DrugBank | DB05295 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.